RankAlpha logo
Back to Rankings

HYPD

Hyperion DeFiD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
HYPD vs peer average
58/100
HYPD vs. peer average (D vs. D)
Grade spread
C 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

MDXH is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $43.95M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMDXHMDxHealth
HYPD
Hyperion DeFi
MDXH
MDxHealth
Grade
D
F
Momentum
74
8
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs MDXH

HYPD / MDXH
Grade Position
In line
HYPD vs. peer average (D vs. D)
58/100
Momentum
74
HYPD
Value
41
HYPD
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HYPD
1
MDXH
MDxHealth SA Common
F
20/100
+1
2
MCRB
Seres Therapeutics Inc Common
D
40/100
Even
3
VERU
Veru Inc Common
F
20/100
+1
4
ELUT
Elutia Inc Class A Common
F
20/100
+1
5
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
F
20/100
+1
MDXH is the first peer returned for this comparison set.